Only medical facilities

Influenza A+B Rapid Test – Positive Control Included

EAN: 04260481081011
Article number
110020
Packaging unit
20 test cassettes, sample dilution buffer, swabs for sample collection, sample containers

Qualitative rapid test for the detection and differentiation of influenza A and influenza B viral antigens in human nasopharyngeal specimens.

€75.00
Excl. 19% VAT , excl. Shipping Cost

Influenza A+B Rapid Test – Rapid Antigen Detection with External Positive Control

The BIOMED Influenza A+B Rapid Test is a qualitative immunochromatographic in vitro diagnostic test designed to detect and differentiate influenza A and influenza B viral antigens in human nasopharyngeal specimens. This instrument-free lateral flow assay provides results within 10 minutes, supporting healthcare professionals in the diagnostic assessment of suspected influenza infections.

A key advantage of the BIOMED Influenza A+B Rapid Test is the external positive control for both influenza A and B included in every kit. This allows additional quality control of the test system and complements the integrated control line on each test cassette.

Each kit contains 20 test cassettes and the necessary components for sample preparation, making it a practical solution for professional use in clinical laboratories, hospitals, medical practices and other healthcare settings.

What Are the Key Benefits of the BIOMED Influenza A+B Rapid Test?

  • Influenza A and B detection in a single test: Qualitative antigen detection with separate test lines for each influenza type.
  • Rapid results: Visual interpretation after just 10 minutes.
  • External positive control included: Control swab containing inactivated influenza A and B antigens for additional quality control.
  • Instrument-free testing: Immunochromatographic lateral flow technology without the need for a dedicated analyser.
  • Multiple specimen types: Suitable for nasopharyngeal swabs, washes and aspirates.
  • 20 tests per kit: Includes sample dilution buffer, collection tubes and sampling swabs.
  • Convenient storage: Store in the original packaging at +2 to +30 °C until the stated expiry date.

Rapid Detection and Differentiation of Influenza A and B

Influenza is an acute viral respiratory infection that plays a significant role in clinical diagnostics, particularly during seasonal influenza outbreaks. As its symptoms can resemble those of other respiratory infections, targeted pathogen detection can provide valuable information for diagnostic assessment.

The Influenza A+B rapid antigen test enables qualitative detection of both influenza types in a single testing procedure. The test cassette features separate detection regions for influenza A (T1) and influenza B (T2).

The assay is also intended to detect influenza A, including subtypes A/H1N1, A/H3N2 and A/H5N1. However, it does not differentiate between individual influenza A subtypes.

Test results are intended to support clinical diagnosis and must be interpreted alongside the patient's clinical presentation and, where appropriate, additional laboratory findings.

Why Is the Included External Positive Control an Important Advantage?

Quality control is an essential aspect of reliable diagnostic testing. In addition to performing the assay correctly, healthcare professionals need to be able to verify that the test system produces the expected reactions.

The BIOMED Influenza A+B Rapid Test provides two distinct control mechanisms.

Internal Procedural Control

Each test cassette contains an integrated control line (C).

The appearance of the green control line indicates that sufficient sample volume has been applied, proper lateral flow has occurred and the internal reagent control has functioned correctly.

External Influenza A+B Positive Control

Every kit additionally includes an external positive control swab containing purified, inactivated influenza A and influenza B antigens.

The positive control is processed in the same way as a patient specimen.

When the control is tested correctly, both red test lines for influenza A and influenza B must appear alongside the green control line.

This external positive control provides an additional means of verifying the positive detection reactions of the test system.

Your advantage: The external influenza A+B positive control is already included in the BIOMED test kit, eliminating the need to purchase it separately.

How Does the Influenza A+B Rapid Test Work?

The Influenza A+B Rapid Test is based on a qualitative lateral flow immunoassay. The test membrane is precoated with specific monoclonal antibodies directed against influenza A and influenza B antigens.

Following sample preparation, the diluted specimen is applied to the test cassette. The liquid migrates along the membrane by capillary action. If the corresponding viral antigens are present, coloured test lines develop in the designated detection regions.

Results are visually interpreted after 10 minutes:

  • Influenza A positive: A red test line at T1 and a green control line at C.
  • Influenza B positive: A red test line at T2 and a green control line at C.
  • Influenza A and B positive: Red test lines at both T1 and T2, together with the green control line at C.
  • Negative: Only the green control line at C is visible.
  • Invalid: The green control line is absent. Testing must be repeated using a new test cassette.

The intensity of the test lines may vary depending on the antigen concentration in the specimen. The assay is qualitative and does not provide a quantitative measurement of viral antigen levels.

Which Specimen Types Can Be Used?

The BIOMED Influenza A+B Rapid Test is intended for the analysis of human nasopharyngeal specimens, including:

  • Nasopharyngeal swabs
  • Nasopharyngeal wash specimens
  • Nasopharyngeal aspirates

Correct specimen collection and preparation are essential for proper test performance.

Specimens should be analysed as soon as possible after collection. If immediate testing is not possible, specimens may be stored and transported at +2 to +8 °C for up to 8 hours before testing.

How Reliable Is the Influenza A+B Rapid Test?

The BIOMED Influenza A+B Rapid Test demonstrates high analytical performance. In comparative testing against another commercially available influenza A/B rapid test, the following performance characteristics were reported:

  • Sensitivity: Greater than 99%
  • Specificity: Greater than 99%
  • Cross-reactivity: No cross-reactivity with respiratory syncytial virus (RSV) or adenovirus was observed in the reported investigations.

These performance figures are based on comparison with another commercial rapid test and should not be interpreted as clinical sensitivity or specificity established against a molecular reference method.

A negative result does not definitively exclude influenza A or influenza B infection. Test results must therefore always be evaluated in conjunction with clinical symptoms and, where necessary, additional diagnostic investigations.

What Is Included in the Influenza A+B Rapid Test Kit?

Each kit contains:

  • 20 Influenza A+B test cassettes
  • 20 sampling swabs
  • 20 sample collection tubes
  • 1 × sample dilution buffer
  • 1 × external Influenza A+B positive control

Additional materials required for testing include disposable gloves, a timer and other equipment depending on the specimen collection method.

Storage and Stability

The Influenza A+B Rapid Test can be stored in its original, unopened packaging at temperatures between +2 and +30 °Cuntil the indicated expiry date.

Do not freeze the test components. Once the aluminium pouch has been opened, the test cassette must be used within 2 hours.

Frequently Asked Questions About the Influenza A+B Rapid Test

How quickly does the Influenza A+B Rapid Test provide results?

Results can be read after 10 minutes. Test lines appearing after this time have no diagnostic value.

Can the test distinguish between influenza A and influenza B?

Yes. The test cassette contains separate detection regions for influenza A and influenza B, allowing both virus types to be detected and differentiated within a single testing procedure.

Is a positive control included in the test kit?

Yes. Each kit includes an external Influenza A+B positive control containing inactivated antigens from both influenza types. It enables additional quality control of the test system.

Does the Influenza A+B Rapid Test require an analyser?

No. The assay is an instrument-free lateral flow test. Results are interpreted visually based on the appearance of the coloured test and control lines.

Who can use the Influenza A+B Rapid Test?

The test is intended for professional in vitro diagnostic use by appropriately trained healthcare personnel, including professionals working in clinical laboratories, hospitals, medical practices and other healthcare facilities.

Does a negative result rule out influenza infection?

No. A negative result does not reliably exclude infection with influenza A or influenza B. Results should always be interpreted in the context of the patient's clinical presentation and, where appropriate, additional diagnostic testing.

Order the Influenza A+B Rapid Test from BIOMED

The BIOMED Influenza A+B Rapid Test provides healthcare professionals with an instrument-free solution for the rapid qualitative detection and differentiation of influenza A and influenza B antigens.

Combining 10-minute results, 20 test cassettes per kit and an included external positive control, the assay offers a practical approach to professional influenza diagnostics.

Explore our complete range of Point-of-Care Rapid Tests for additional diagnostic solutions in respiratory and gastrointestinal testing.

More Information
Parameter Influenza A+B
Packaging unit 20 test cassettes, sample dilution buffer, swabs for sample collection, sample containers
are usually dispatched on the same day (no dispatch on Fridays)
Orders placed before 12 noon
are usually dispatched on the same day (no dispatch on Fridays)
in an environmentally friendly box
Refrigerated shipping
in an environmentally friendly box
from 2.000 € Germany-wide
Free shipping
from 2.000 € Germany-wide